| [1] |
|
| [2] |
Yang X, Wang Q, Shao F, et al. Cell volume regulation modulates macrophage-related inflammatory responses via JAK/STAT signaling pathways[J]. Acta Biomater, 2024, 186: 286-299. DOI: 10.1016/j.actbio.2024.07.046.
|
| [3] |
Yasen A, Li W, Ran B, et al. Identification of infiltrating immune cell subsets and heterogeneous macrophages in the lesion microenvironment of hepatic cystic echinococcosis patients with different cyst viability[J]. Acta Trop, 2021, 221: 106029. DOI: 10.1016/j.actatropica.2021.106029.
|
| [4] |
Wang H, Li Y, Yu Q, et al. Immunological characteristics of hepatic dendritic cells in patients and mouse model with liver Echinococcus multilocularis infection[J]. Trop Med Infect Dis, 2024, 9(5): 95. DOI: 10.3390/tropicalmed9050095.
|
| [5] |
Wang L, Wu K, Li L, et al. Regulation of host regulatory T cell differentiation by emu-let-7-5p in Echinococcus multilocularis infection through targeting NFκB2[J]. FASEB J, 2025, 39(9): e70603. DOI: 10.1096/fj.202403437R.
|
| [6] |
Oppmann B, Lesley R, Blom B, et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12[J]. Immunity, 2000, 13(5): 715-725. DOI: 10.1016/s1074-7613(00)00070-4.
|
| [7] |
Bloch Y, Felix J, Merceron R, et al. Structures of complete extracellular receptor assemblies mediated by IL-12 and IL-23[J]. Nat Struct Mol Biol, 2024, 31(4): 591-597. DOI: 10.1038/s41594-023-01190-6.
|
| [8] |
D’Haens G, Panaccione R, Baert F, et al. Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials[J]. Lancet, 2022, 399(10340): 2015-2030. DOI: 10.1016/S0140-6736(22)00467-6.
|
| [9] |
Risankizumab induction therapy in patients with moderately to severely active ulcerative colitis: efficacy and safety in the randomized phase 3 INSPIRE study[J]. Gastroenterol Hepatol, 2023, 19(12 Suppl 9): 9-10.
|
| [10] |
Zhou JR, Du XX, Abulajiang X, et al. The role of memory T cells in Echinococcus granulosus-induced sensitization[J]. Immun Inflamm Dis, 2023, 11(8): e948. DOI: 10.1002/iid3.948.
|
| [11] |
Nicolao MC, Rodrigues CR, Coccimiglio MB, et al. Characterization of protein cargo of Echinococcus granulosus extracellular vesicles in drug response and its influence on immune response[J]. Parasit Vectors, 2023, 16(1): 255. DOI: 10.1186/s13071-023-05854-6.
|
| [12] |
Wang M, Qiao F, Li Z, et al. Impact of Echinococcus granulosus antigens on monocyte development and dendritic cell differentiation[J]. Iran J Immunol, 2023, 20(3): 348-358. DOI: 10.22034/iji.2023.98163.2557.
|
| [13] |
Wu J, Ma HZ, Apaer S, et al. Impact of albendazole on cytokine and chemokine response profiles in Echinococcus multilocularis-inoculated mice[J]. Biomed Res Int, 2021, 2021: 6628814. DOI: 10.1155/2021/6628814.
|
| [14] |
Dabbaghizadeh A, Dion J, Maali Y, et al. Novel RORγt inverse agonists limit IL-17-mediated liver inflammation and fibrosis[J]. J Immunol, 2025, 214(6): 1321-1331. DOI: 10.1093/jimmun/vkaf014.
|
| [15] |
Kaur P, Prabhahar A, Pal D, et al. IL-23/IL-17 in a paradoxical association with primary membranous nephropathy[J]. Inflammation, 2024, 47(4): 1536-1544. DOI: 10.1007/s10753-024-01992-w.
|
| [16] |
Askoura M, Abbas HA, Al Sadoun H, et al. Elevated levels of IL-33, IL-17 and IL-25 indicate the progression from chronicity to hepatocellular carcinoma in hepatitis C virus patients[J]. Pathogens, 2022, 11(1): 57. DOI: 10.3390/pathogens11010057.
|
| [17] |
Al-Masoudi HK, Al-Hamadani KC, Khiarull IA. Interleukin 17 cytokine profiles in patients with cystic echinococcosis in Babylon province, Iraq[J]. Arch Razi Inst, 2021, 76(5): 1493-1500. DOI: 10.22092/ari.2021.355855.1730.
|
| [18] |
Yang J, Zhao Y, Fu Y, et al. Recombinant antigen P29 of Echinococcus granulosus induces Th1, Tc1, and Th17 cell immune responses in sheep[J]. Front Immunol, 2023, 14: 1243204. DOI: 10.3389/fimmu.2023.1243204.
|
| [19] |
Yasen A, Li W, Aini A, et al. Th1/Th2/Th17 cytokine profile in hepatic cystic Echinococcosis patients with different cyst stages[J]. Parasite Immunol, 2021, 43(7): e12839. DOI: 10.1111/pim.12839.
|
| [20] |
Hou X, Shi Y, Kang X, et al. Echinococcus granulosus: the establishment of the metacestode in the liver is associated with control of the CD4 + T-cell-mediated immune response in patients with cystic echinococcosis and a mouse model[J]. Front Cell Infect Microbiol, 2022, 12: 983119. DOI: 10.3389/fcimb.2022.983119.
|
| [21] |
Yang S, Du X, Wang C, et al. Coding and noncoding RNA expression profiles of spleen CD4 + T lymphocytes in mice with echinococcosis[J]. Contrast Media Mol Imaging, 2022, 2022: 9742461. DOI: 10.1155/2022/9742461.
|
| [22] |
Ghabdian S, Parande Shirvan S, Maleki M, et al. Exacerbation of allergic asthma by somatic antigen of Echinococcus granulosus in allergic airway inflammation in BALB/c mice[J]. Parasit Vectors, 2022, 15(1): 16. DOI: 10.1186/s13071-021-05125-2.
|
| [23] |
Li B, Qi X, Liu Y, et al. Monocyte-derived macrophages: the supplements of hepatic macrophage in Echinococcus multilocularis infected mice[J]. Immun Inflamm Dis, 2022, 10(10): e699. DOI: 10.1002/iid3.699.
|
| [24] |
Han S, Kim B, Hyeon DY, et al. Distinctive CD39 +CD9 + lung interstitial macrophages suppress IL-23/Th17-mediated neutrophilic asthma by inhibiting NETosis[J]. Nat Commun, 2024, 15(1): 8628. DOI: 10.1038/s41467-024-53038-2.
|
| [25] |
Khan S, Bilal H, Khan MN, et al. Interleukin inhibitors and the associated risk of candidiasis[J]. Front Immunol, 2024, 15: 1372693. DOI: 10.3389/fimmu.2024.1372693.
|
| [26] |
Li H, Tsokos MG, Bhargava R, et al. IL-23 reshapes kidney resident cell metabolism and promotes local kidney inflammation[J]. J Clin Invest, 2021, 131(12): e142428. DOI: 10.1172/JCI142428.
|
| [27] |
Reuveni D, Brezis MR, Brazowski E, et al. Interleukin 23 produced by hepatic monocyte-derived macrophages is essential for the development of murine primary biliary cholangitis[J]. Front Immunol, 2021, 12: 718841. DOI: 10.3389/fimmu.2021.718841.
|
| [28] |
Hu X, Li J, Fu M, et al. The JAK/STAT signaling pathway: from bench to clinic[J]. Signal Transduct Target Ther, 2021, 6(1): 402. DOI: 10.1038/s41392-021-00791-1.
|
| [29] |
McInnes IB, Szekanecz Z, McGonagle D, et al. A review of JAK-STAT signalling in the pathogenesis of spondyloarthritis and the role of JAK inhibition[J]. Rheumatology, 2022, 61(5): 1783-1794. DOI: 10.1093/rheumatology/keab740.
|
| [30] |
Schinocca C, Rizzo C, Fasano S, et al. Role of the IL-23/IL-17 pathway in rheumatic diseases: an overview[J]. Front Immunol, 2021, 12: 637829. DOI: 10.3389/fimmu.2021.637829.
|
| [31] |
Park H, Lee S, Lee J, et al. Exploring the JAK/STAT signaling pathway in hepatocellular carcinoma: unraveling signaling complexity and therapeutic implications[J]. Int J Mol Sci, 2023, 24(18): 13764. DOI: 10.3390/ijms241813764.
|